Merck Overview
- Status
- Public
- Employees
- 58,077

- Stock Symbol
- MRK

- Investments
- 72
- Share Price
- $179.56
- (As of Monday Closing)
Merck General Information
Description
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Contact Information
- Frankfurter Straße 250
- 64293 Darmstadt
- Germany
Merck Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$179.56 | $180.91 | $83.54 - $182.36 | $78.1B | 435M | 477K | $4.81 |
Merck Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 77,736,444 | 59,166,046 | 56,639,343 | 58,961,749 |
Revenue | 19,383,038 | 18,081,272 | 17,507,464 | 16,371,756 |
EBITDA | 5,486,843 | 4,571,812 | 4,173,895 | 4,761,421 |
Net Income | 2,091,985 | 1,477,667 | 3,981,544 | 2,937,826 |
Total Assets | 50,755,503 | 49,075,858 | 42,196,294 | 42,734,602 |
Total Debt | 16,037,570 | 14,695,537 | 10,072,066 | 12,847,614 |
Merck Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.
Request a free trialMerck Comparisons
Industry
00000000
00000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMerck Competitors (40)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Catalent | Formerly PE-Backed | Somerset, NJ | 00000 | 00.000 | 00000000 | 00.000 |
00000 | Corporation | Port Washington, NY | 000 | 0000000000. | ||
00000 | Corporation | Leverkusen, Germany | 000000 | 00.00 | 000000000 | 00.00 |
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
000000000000000 | Corporation | Brentford, United Kingdom | 00000 | 00000000000 |
Merck Executive Team (44)
Merck Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
00000 000000 | Self | Vice Chairman of Executive Board & Deputy CEO | 000 0000 |
00000 00000000 | Self | Board Member & Chief Executive Officer, Life Science & Performance Materials | 000 0000 |
000000000 00000 00.0 | Merck | Chairman | 000 0000 |
000 00000000 00.0 | Merck | Chief Administration Officer & Member of the Executive Board | 000 0000 |
000000 0000000 00.0 | Merck | Member of the Executive Board & Chief Financial Officer | 000 0000 |
Merck Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMerck Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.
Request a free trialMerck Investments & Acquisitions (72)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 | 07-Jan-2021 | 000000000000000000 | BPO/Outsource Services | 0000000 00000000 00.0 | |
0000000 00000000 | 14-Sep-2020 | 0000 | 000 | Drug Discovery | 00000 0000000000 |
000000000 | 11-Sep-2020 | 00000 00000 00 | 0000 | Other Healthcare Technology Systems | |
000 000000 | 29-Jul-2020 | 00000 00000 00 | 0000 | Biotechnology | |
Resolution Spectra Systems | 01-Jul-2020 | Merger/Acquisition | Other Healthcare Technology Systems | 000000 000000 |
Merck Subsidiaries (21)
Company Name | Industry | Location | Founded |
---|---|---|---|
ConnectMed | Outcome Management (Healthcare) | Kenya | 2015 |
00000 0000000000 0 | Accelerator/Incubator | Darmstadt, Germany | 0000 |
0000 00000000 | Business/Productivity Software | Darmstadt, Germany | 0000 |
0000000000 0000000 | Other Healthcare Technology Systems | Meylan, France | 0000 |
0 00000000 | Corporate Venture Capital | Amsterdam, Netherlands | 0000 |
Merck Exits (7)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000 | 07-Sep-2012 | 000000000 00000 00 | 00000 | Completed |
|
0000000 0000000000 | 18-Jul-2008 | 00000 00000 00 | 0000 | Completed |
|
00000000 | 11-Jun-2007 | 00000 00000 00 | 000.00 | Completed |
|
00000 00000000 000 | 08-Jun-2006 | 000000000 00000000 | Completed |
|
|
Prasfarma | 15-Sep-2005 | Merger/Acquisition | 000.00 | Completed |